Chang-Bin Jing (Changbin Jing)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Acute Lymphoblastic Leukemia

Circulating Tumor

Top Venues

Science immunology

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Oct 01 2014

United States

Research Fellow :: Pediatric Oncology

Publications

Sai Luo, Jun Zhang, Alex J B Kreutzberger, Amanda Eaton, Robert J Edwards, Chang-Bin Jing, Hai-Qiang Dai, Gregory D Sempowski, Kenneth Cronin, Robert Parks, Adam Yongxin Ye, Katayoun Mansouri, Maggie Barr, Novalia Pishesha, Aimee Chapdelaine Williams, Lucas Vieira Francisco, Anand Saminathan, Hanqin Peng, Himanshu Batra, Lorenza Bellusci, Surender Khurana, S Munir Alam, David C Montefiori, Kevin O Saunders, Ming Tian, Hidde L Ploegh, Tomas Kirchhausen, Bing Chen, Barton F Haynes, Frederick W Alt
An antibody from single human V H -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion. Science immunology 7 (76) (2022)
Chang-Bin Jing, Cong Fu, Nicole Prutsch, Meng Wang, Shuning He, A Thomas Look
Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells (HSPCs) with TOP1-targeted drugs and PARP1 inhibitors. Leukemia 34 (11) (2020)